These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24738665)

  • 1. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
    Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
    Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
    Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
    Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
    Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
    Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
    Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
    J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
    Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
    Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
    Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
    J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.
    Stoyianni A; Goussia A; Pentheroudakis G; Siozopoulou V; Ioachim E; Krikelis D; Golfinopoulos V; Cervantes A; Bobos M; Fotsis T; Bellou S; Fountzilas G; Malamou-Mitsi V; Pavlidis N
    Anticancer Res; 2012 Apr; 32(4):1273-81. PubMed ID: 22493359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma.
    Ding L; Zhang Z; Shang D; Cheng J; Yuan H; Wu Y; Song X; Jiang H
    J Oral Pathol Med; 2014 May; 43(5):335-43. PubMed ID: 24313357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
    Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
    Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
    Schmidt U; Heller G; Timelthaler G; Heffeter P; Somodi Z; Schweifer N; Sibilia M; Berger W; Csiszar A
    J Exp Clin Cancer Res; 2021 Feb; 40(1):69. PubMed ID: 33596971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer.
    Saito S; Okabe H; Watanabe M; Ishimoto T; Iwatsuki M; Baba Y; Tanaka Y; Kurashige J; Miyamoto Y; Baba H
    Oncol Rep; 2013 Apr; 29(4):1570-8. PubMed ID: 23404221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer.
    Yamada S; Fuchs BC; Fujii T; Shimoyama Y; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y; Nakao A
    Surgery; 2013 Nov; 154(5):946-54. PubMed ID: 24075276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer.
    Zhao J; Dong D; Sun L; Zhang G; Sun L
    Int Braz J Urol; 2014; 40(2):179-89. PubMed ID: 24856504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition and clinicopathological correlation in craniopharyngioma.
    Qi ST; Zhou J; Pan J; Zhang C; Silky C; Yan XR
    Histopathology; 2012 Oct; 61(4):711-25. PubMed ID: 23551434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale.
    Paliwal P; Arora D; Mishra AK
    Indian J Pathol Microbiol; 2012; 55(4):443-9. PubMed ID: 23455777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.
    Aruga N; Kijima H; Masuda R; Onozawa H; Yoshizawa T; Tanaka M; Inokuchi S; Iwazaki M
    Tokai J Exp Clin Med; 2018 Apr; 43(1):5-13. PubMed ID: 29637533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.